Nathalie ter Wengel

European Lead Worldwide Business Development at Pfizer at Pfizer

Speaker

Nathalie ter Wengel M.D. is the European Lead Worldwide Business Development and Global Scouting Team Leader at Pfizer, where she is responsible for establishing new collaborations and exploring global licensing and other corporate development opportunities across all therapeutic areas that Pfizer is interested in with European companies. In addition, she leads a team at Pfizer responsible for conferences, sourcing and due diligence for global license, co-development/co-commercialization, and acquisition transactions. Previous to this role, she was the European Head for External Science & Innovation at Pfizer. Nathalie obtained her Doctor of Medicine degree at the Vrije Universiteit in Amsterdam. She has an international background and a broad knowledge in the medical field, having worked in the hospital with extensive experience in Internal Medicine. Nathalie started her commercial career as European Medical Manager at Pfizer. Consequently, she started up a company called myTomorrows focused on compassionate use, where she served as Chief Medical Officer before joining Galapagos as Business Development Director, where she played a key role in the NASDAQ IPO and in the partnering of filgotinib.